CIK 0001840439 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Biomea Fusion, Inc.
Sign in to watch- Ticker
- BMEA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 980-9099
- Business address
- 1599 INDUSTRIAL ROAD, SAN CARLOS, CA, 94070
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 5 Insider Annual Insider Trading Report
- 8-K Event Regulation FD disclosure · Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Open-market buy See Remarks bought 30,000 shares at $1.43 ($42,999)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market buy Interim CEO bought 100,000 shares at $0.99 ($99,180)
- 4 Open-market buy See Remarks bought 50,000 shares at an average $1.09 ($54,552)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
Page 2 of 15 · 292 filings